Skip to main content
Log in

Photodynamische Therapie bei kutaner Leishmaniose

Eine viel versprechende neue Therapiemodalität

Photodynamic therapy of cutaneous leishmaniasis

A promising new therapeutic modality

  • Kurzkasuistik
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Wir berichten über einen 19-jährigen türkischen Patienten, der sich nach einem Urlaub in seinem Heimatland mit einer kutanen Leishmaniose infizierte. Die kutane Leishmaniose heilt häufig spontan mit einer lebenslangen Immunität ab, kann aber auch persistieren und zu ausgedehnter Narbenbildung führen. In der Literatur sind bis heute zwar viele therapeutische Optionen beschrieben, diese gehen aber teilweise mit erheblichen Nebenwirkungen einher. Bei unserem Patienten führte die photodynamische Therapie zu einer Abheilung der Läsion mit nur geringgradig ausgeprägter Hypopigmentierung.

Abstract

We report about a 19-year-old Turkish patient who presented with cutaneous leishmaniasis after a holiday in Turkey. Cutaneous leishmaniasis often heals spontaneously leading to life-long immunity, but it can persist and lead to extensive scarring. In the literature, many therapeutic modalities have been reported; however, they can be accompanied by severe side effects. In our patient, photodynamic therapy resulted in healing of the lesion with only slight hypopigmentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Abok K, Cadenas E, Brunk U (1988) An experimental model system for leishmaniasis. Effects of porphyrin-compounds and menadione on leishmania parasites engulfed by cultured macrophages. APMIS 96:543–551

    CAS  PubMed  Google Scholar 

  2. Bahamdan KA, Tallab TM, Johargi H et al. (1997) Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study. Int J Dermatol 36:59–60

    Article  CAS  PubMed  Google Scholar 

  3. Bassiouny A, Meshad M, Tallaat M (1982) Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 107:467–474

    CAS  PubMed  Google Scholar 

  4. Bermarn JD (1997) Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developements in the last 10 years. Clin Infect Dis 24:684–703

    CAS  PubMed  Google Scholar 

  5. Davidson RN (1998) Practical guide for the treatment of Leishmaniasis. Drugs 56:1009–1018

    CAS  PubMed  Google Scholar 

  6. Dogra J, Aneja N, Lal BB, Mishra SN (1990) Cutaneous leishmaniasis in India: clinical experience with itraconazole (R51 211 Janssen). Int J Dermatol 29:661–662

    CAS  PubMed  Google Scholar 

  7. Enk CD, Fritsch C, Jonas F et al. (2003) Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 139:432–434

    Article  PubMed  Google Scholar 

  8. Enk CD, Gardlo K, Hochberg M et al. (2003) Cutaneous leishmaniasis. Hautarzt 54:506–512

    CAS  PubMed  Google Scholar 

  9. Faris RM, Jarallah JS, Khoja TA, Al Yamani MJ (1993) Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 32:610–612

    CAS  PubMed  Google Scholar 

  10. Gardlo K, Enk CD, Horska Z et al. (2003) Effective treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 48:893–896

    Article  PubMed  Google Scholar 

  11. Grevenik SA, Lerner EA (1996) Leishmaniasis. J Am Acad Dermatol 34:257–277

    Google Scholar 

  12. Hepburn NC (2000) Cutaneous leishmaniasis. Br J Dermatol 25:363–370

    Article  CAS  Google Scholar 

  13. Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191–1199

    CAS  PubMed  Google Scholar 

  14. Herwaldt BL, Berman JD (1992) Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46:296–306

    CAS  PubMed  Google Scholar 

  15. Kubba R, Al-Gindan Y, el-Hassan AM, Omer AH (1987) Clinical diagnosis of cutaneous leishmaniasis (oriental sore). J Am Acad Derm 16:1183–1189

    CAS  PubMed  Google Scholar 

  16. Levine N (1992) Cutaneous leishmaniasis treated with controlled localized heating. Arch Dermatol 128:759–761

    Article  CAS  PubMed  Google Scholar 

  17. Moskowitz PF, Kurban AK (1999) Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century. Clin Dermatol 17:305–315

    Article  CAS  PubMed  Google Scholar 

  18. Navin TR, Arana BA, Arana FE et al. (1992) Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 165:528–534

    CAS  PubMed  Google Scholar 

  19. Saldanta AC, Romeo GA, Merchan-Haman E et al. (1999) A comparative study between sodium stibogluconate BP 88R and Meglumine antimoniate in the treatment of cutaneous leishmaniasis: the efficacy and safety. Rev Soc Bras Med Trop 32:383–387

    PubMed  Google Scholar 

  20. Stojiljkovic I, Evavold BD, Kumar V (2001) Antimicrobial properties of porphyrins. Expert Opin Invest Drugs 10:309–320

    CAS  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. J. Neumann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gardlo, K., Hanneken, S., Ruzicka, T. et al. Photodynamische Therapie bei kutaner Leishmaniose. Hautarzt 55, 381–383 (2004). https://doi.org/10.1007/s00105-004-0710-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-004-0710-y

Navigation